Friday, 17 March 2017

VACCINE Against Diabetes

Vaccine Against Diabetes

Good news for all the physicians who treat diabetic patients.

 The vaccine for diabetes has been officially announced.

 A vaccine issued over 100 years ago for tuberculosis has shown promise in reversing diabetes.

The FDA has approved a mid-stage trial to test the vaccine, called bacillus Calmette-Guerin (BCG), in 150 adults who are in the advanced stage of type one diabetes.

Previous clinical trials of the vaccine injected twice within a four-week time frame have reported increase the level of tumor necrosis factor (TNF) in diabetic patients. The increased level of TNF in the system destroys the T cells that hamper the production of insulin. Moreover, the recent phase I trial of the vaccine has testified a significant response to BCG. However, further research is needed to create a long lasting therapeutic response.

Based on the results of recent clinical trials, this official announcement was made at 75th Scientific Sessions of the American Diabetes Association.



Do you think this update can be considered as a breakthrough in the management of diabetes mellitus?

No comments:

Post a Comment